Work

Benralizumab‐resistant mucus plugs in severe asthma complicated by eosinophilic chronic rhinosinusitis

Year: 2024

Type: article

Abstract: It is an absolute necessity to achieve complete control of comorbidities to obtain optimal asthma control. Importantly, type 2 asthma and ECRS share the same inflammatory pathophysiology and are common co-morbidities. If the initial biologic is insufficiently effective, it is worth considering an alternative biologic.

Source: Respirology Case Reports

DOI: 10.1002/rcr2.70009

Authors: Masamitsu Hamakawa, Tadashi Ishida

Institution: Kurashiki Central Hospital

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,130